Cutaneous and serologic subsets of systemic sclerosis

C. Ferri, L. Bernini, R. Cecchetti, A. Latorraca, G. Marotta, G. Pasero, R. Neri, S. Bombardieri

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

The relevance of the extent of skin sclerosis and of other clinicoserological features in diagnosis, severity and prognosis of disease was studied in a large number of unselected patients with systemic sclerosis (SSc). One hundred and fifty-one patients with SSc (126 F and 25 M, mean age 48 ± 14 SD) followed for 5.3 ± 3.2 years were included. Patients were divided into 3 cutaneous subsets: limited (68), intermediate (46) and diffuse SSc (37). Serological markers were detected in 288 patients with Raynaud's phenomenon and other connective tissue diseases (CTD). Limited and intermediate SSc prevailed in female patients while the diffuse subset was more frequent in males (p <0.0001). Duration of Raynaud's phenomenon before disease onset was shorter in the diffuse variant (p <0.0001). A wider cutaneous involvement was associated with more severe forms of SSc. Diffuse subset showed the poorest prognosis at 10 years of followup compared with intermediate (p <0.05) and limited variant (p <0.001). Intermediate SSc seems a distinct variant of SSc on the basis of clinical manifestations and survival. Among serological markers, anticentromere, anti-Scl-70 and antinucleolar antibodies were found in 21, 40 and 27% of the cases, respectively; these were statistically less frequent (p <0.0001) in other CTD. In 83.5% of patients with SSc at least one of these specific markers was recorded. Anticentromere antibodies were correlated to sex (female), limited SSc, calcinosis and telangiectasia. On the contrary anti-Scl-70 was associated with diffuse and intermediate subsets and with more severe SSc manifestations. Our results underline the clinical and prognostic usefulness of cutaneous subsets in patients with scleroderma and the diagnostic value of the serological markers.

Original languageEnglish
Pages (from-to)1826-1832
Number of pages7
JournalJournal of Rheumatology
Volume18
Issue number12
Publication statusPublished - 1991

Fingerprint

Systemic Scleroderma
Skin
Diffuse Scleroderma
Raynaud Disease
Connective Tissue Diseases
Calcinosis
Telangiectasis
Sclerosis
Survival
Antibodies

Keywords

  • anti-Scl-70 antibody
  • anticentromere antibody
  • cutaneous subsets
  • scleroderma survival
  • systemic sclerosis

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Ferri, C., Bernini, L., Cecchetti, R., Latorraca, A., Marotta, G., Pasero, G., ... Bombardieri, S. (1991). Cutaneous and serologic subsets of systemic sclerosis. Journal of Rheumatology, 18(12), 1826-1832.

Cutaneous and serologic subsets of systemic sclerosis. / Ferri, C.; Bernini, L.; Cecchetti, R.; Latorraca, A.; Marotta, G.; Pasero, G.; Neri, R.; Bombardieri, S.

In: Journal of Rheumatology, Vol. 18, No. 12, 1991, p. 1826-1832.

Research output: Contribution to journalArticle

Ferri, C, Bernini, L, Cecchetti, R, Latorraca, A, Marotta, G, Pasero, G, Neri, R & Bombardieri, S 1991, 'Cutaneous and serologic subsets of systemic sclerosis', Journal of Rheumatology, vol. 18, no. 12, pp. 1826-1832.
Ferri C, Bernini L, Cecchetti R, Latorraca A, Marotta G, Pasero G et al. Cutaneous and serologic subsets of systemic sclerosis. Journal of Rheumatology. 1991;18(12):1826-1832.
Ferri, C. ; Bernini, L. ; Cecchetti, R. ; Latorraca, A. ; Marotta, G. ; Pasero, G. ; Neri, R. ; Bombardieri, S. / Cutaneous and serologic subsets of systemic sclerosis. In: Journal of Rheumatology. 1991 ; Vol. 18, No. 12. pp. 1826-1832.
@article{31413a75a0ee48cda0383fbf12345fd2,
title = "Cutaneous and serologic subsets of systemic sclerosis",
abstract = "The relevance of the extent of skin sclerosis and of other clinicoserological features in diagnosis, severity and prognosis of disease was studied in a large number of unselected patients with systemic sclerosis (SSc). One hundred and fifty-one patients with SSc (126 F and 25 M, mean age 48 ± 14 SD) followed for 5.3 ± 3.2 years were included. Patients were divided into 3 cutaneous subsets: limited (68), intermediate (46) and diffuse SSc (37). Serological markers were detected in 288 patients with Raynaud's phenomenon and other connective tissue diseases (CTD). Limited and intermediate SSc prevailed in female patients while the diffuse subset was more frequent in males (p <0.0001). Duration of Raynaud's phenomenon before disease onset was shorter in the diffuse variant (p <0.0001). A wider cutaneous involvement was associated with more severe forms of SSc. Diffuse subset showed the poorest prognosis at 10 years of followup compared with intermediate (p <0.05) and limited variant (p <0.001). Intermediate SSc seems a distinct variant of SSc on the basis of clinical manifestations and survival. Among serological markers, anticentromere, anti-Scl-70 and antinucleolar antibodies were found in 21, 40 and 27{\%} of the cases, respectively; these were statistically less frequent (p <0.0001) in other CTD. In 83.5{\%} of patients with SSc at least one of these specific markers was recorded. Anticentromere antibodies were correlated to sex (female), limited SSc, calcinosis and telangiectasia. On the contrary anti-Scl-70 was associated with diffuse and intermediate subsets and with more severe SSc manifestations. Our results underline the clinical and prognostic usefulness of cutaneous subsets in patients with scleroderma and the diagnostic value of the serological markers.",
keywords = "anti-Scl-70 antibody, anticentromere antibody, cutaneous subsets, scleroderma survival, systemic sclerosis",
author = "C. Ferri and L. Bernini and R. Cecchetti and A. Latorraca and G. Marotta and G. Pasero and R. Neri and S. Bombardieri",
year = "1991",
language = "English",
volume = "18",
pages = "1826--1832",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "12",

}

TY - JOUR

T1 - Cutaneous and serologic subsets of systemic sclerosis

AU - Ferri, C.

AU - Bernini, L.

AU - Cecchetti, R.

AU - Latorraca, A.

AU - Marotta, G.

AU - Pasero, G.

AU - Neri, R.

AU - Bombardieri, S.

PY - 1991

Y1 - 1991

N2 - The relevance of the extent of skin sclerosis and of other clinicoserological features in diagnosis, severity and prognosis of disease was studied in a large number of unselected patients with systemic sclerosis (SSc). One hundred and fifty-one patients with SSc (126 F and 25 M, mean age 48 ± 14 SD) followed for 5.3 ± 3.2 years were included. Patients were divided into 3 cutaneous subsets: limited (68), intermediate (46) and diffuse SSc (37). Serological markers were detected in 288 patients with Raynaud's phenomenon and other connective tissue diseases (CTD). Limited and intermediate SSc prevailed in female patients while the diffuse subset was more frequent in males (p <0.0001). Duration of Raynaud's phenomenon before disease onset was shorter in the diffuse variant (p <0.0001). A wider cutaneous involvement was associated with more severe forms of SSc. Diffuse subset showed the poorest prognosis at 10 years of followup compared with intermediate (p <0.05) and limited variant (p <0.001). Intermediate SSc seems a distinct variant of SSc on the basis of clinical manifestations and survival. Among serological markers, anticentromere, anti-Scl-70 and antinucleolar antibodies were found in 21, 40 and 27% of the cases, respectively; these were statistically less frequent (p <0.0001) in other CTD. In 83.5% of patients with SSc at least one of these specific markers was recorded. Anticentromere antibodies were correlated to sex (female), limited SSc, calcinosis and telangiectasia. On the contrary anti-Scl-70 was associated with diffuse and intermediate subsets and with more severe SSc manifestations. Our results underline the clinical and prognostic usefulness of cutaneous subsets in patients with scleroderma and the diagnostic value of the serological markers.

AB - The relevance of the extent of skin sclerosis and of other clinicoserological features in diagnosis, severity and prognosis of disease was studied in a large number of unselected patients with systemic sclerosis (SSc). One hundred and fifty-one patients with SSc (126 F and 25 M, mean age 48 ± 14 SD) followed for 5.3 ± 3.2 years were included. Patients were divided into 3 cutaneous subsets: limited (68), intermediate (46) and diffuse SSc (37). Serological markers were detected in 288 patients with Raynaud's phenomenon and other connective tissue diseases (CTD). Limited and intermediate SSc prevailed in female patients while the diffuse subset was more frequent in males (p <0.0001). Duration of Raynaud's phenomenon before disease onset was shorter in the diffuse variant (p <0.0001). A wider cutaneous involvement was associated with more severe forms of SSc. Diffuse subset showed the poorest prognosis at 10 years of followup compared with intermediate (p <0.05) and limited variant (p <0.001). Intermediate SSc seems a distinct variant of SSc on the basis of clinical manifestations and survival. Among serological markers, anticentromere, anti-Scl-70 and antinucleolar antibodies were found in 21, 40 and 27% of the cases, respectively; these were statistically less frequent (p <0.0001) in other CTD. In 83.5% of patients with SSc at least one of these specific markers was recorded. Anticentromere antibodies were correlated to sex (female), limited SSc, calcinosis and telangiectasia. On the contrary anti-Scl-70 was associated with diffuse and intermediate subsets and with more severe SSc manifestations. Our results underline the clinical and prognostic usefulness of cutaneous subsets in patients with scleroderma and the diagnostic value of the serological markers.

KW - anti-Scl-70 antibody

KW - anticentromere antibody

KW - cutaneous subsets

KW - scleroderma survival

KW - systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=0026348469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026348469&partnerID=8YFLogxK

M3 - Article

C2 - 1795320

AN - SCOPUS:0026348469

VL - 18

SP - 1826

EP - 1832

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 12

ER -